300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Oil and Gas
Construction
Mobile
Payments
Retail
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Software
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Sudan
Norway
Malawi
Isle of Man
Haiti
Iran
Madagascar
Lesotho
Russian Federation
Nepal
Turkey
Liberia
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Armenia
Colombia
China
Côte d'Ivoire
Costa Rica
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Kazakhstan
Switzerland
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Novo Holdings, VC Fund

Novo Holdings

VC Fund

Hellerup, Denmark

Novo Holdings is a holding and investment firm that manages the assets of the Novo Nordisk Foundation. It is a life science investor with a diverse portfolio that includes equities, bonds, real estate, infrastructure, and private investments.

Total investments:
415
Last investment:
Lead investor:
40%
Fund size:
$165M
Last fund:

Last updated:

Industries Novo Holdings invests in

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Stages Novo Holdings invests in

Series ASeries BSeries CVenture - Series UnknownSeed

Countries Novo Holdings invests in

United StatesDenmarkUnited KingdomSwitzerlandSweden

Round sizes

Series A $9.5M–$133MSeries B $15M–$135MSeries C $35M–$118M

Contacts

NameEmailPhoneSocials
See all 17 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$9.5M–$133M
Series B
$15M–$135M
Series C
$35M–$118M

Investment Focus

Industry

  • Biotechnology 170 (41%)
  • Health Care 126 (30%)
  • Medical 76 (18%)
  • Pharmaceutical 65 (16%)
  • Therapeutics 63 (15%)
See all 92 industries →

Stage

  • Series A 94 (23%)
  • Series B 71 (17%)
  • Series C 51 (12%)
  • Venture - Series Unknown 35 (8%)
  • Seed 18 (4%)
See all 16 stages →

Country

  • United States 121 (29%)
  • Denmark 40 (10%)
  • United Kingdom 23 (6%)
  • Switzerland 12 (3%)
  • Sweden 7 (2%)
See all 19 countries →

Team

NameTitleInvestmentsLinksEmail
Emmanuelle Coutanceau
Emmanuelle Coutanceau Partner Novo Seeds
Partner Novo Seeds Total investments: 10
Find email
Steve Collins
Steve Collins National Account Executive
National Account Executive Total investments: 1
Find email
Thomas Dyrberg
Thomas Dyrberg Partner
Partner Total investments: 17
Find email
Thomas Grotkjær
Thomas Grotkjær Investor & Principal
Investor & Principal Total investments: 12
Find email
Abhijeet Lele
Abhijeet Lele Senior Partner and Head of US Principal Investments
Senior Partner and Head of US Principal Investments Total investments: 6
Find email
See all 17 team members →

Investments

CompanyDescriptionRoundLinks
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets. $310M / Series C / Oct 15, 2026
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure. $70.8M / Series B / Sep 30, 2026
Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases. $76.7M / Series A / Sep 29, 2026
ForYou Medical develops and manufactures Advanced wound care dressings, hemostats, and biodegradable materials. Foryou is committed to offering comprehensive care to customers and patients. Private Equity / Sep 10, 2026
CaMaRa CaMaRa
CaMaRa is a biotechnology company developing new medicines for cardiometabolic conditions, including obesity, diabetes and kidney disease. Seed / Sep 09, 2026
Expedition Therapeutics operates as an unincorporated association. $115M / Series B / Aug 05, 2026
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment. $118M / Series B / Jul 28, 2026
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout. $130M / Series B / Jul 22, 2026
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based protein in a sustainable way. It's a spin-out from BioscienZ and is commercializing innovative protein production using fermentation. It was founded by Wim de Laat in 2019 and is based in Breda, Noord-Brabant, The Netherlands. $20.5M / Series B / Jun 29, 2026
HSTpathways will raise the level of excellence for providing Information Technology and IT Services to Outpatient Healthcare Providers. In every industry, a clear market leader emerges and delivers exceptional value and service to their customers. HSTpathways demonstrates its leadership with superior solutions for both the enterprise multi-facilitycustomer as well as the freestanding surgical centers. Together, with customers as partners, HSTpathways will continually improve upon its Information Technology to reflect best practices. HSTpathways will become an important Strategic Business Asset and indispensable to senior and executive management.HSTpathways' leadership, management, and staff will tirelessly pursue quality improvement processes. They continuously strive to develop reliable software and provide excellent customer service in a way that is consistent, repeatable, and cost effective for their customers. They are committed to listening to their customers and to understanding how the industry is evolving. They will incorporate these new requirements and changes as part of regular and prompt software updates. As a customer, you will experience this commitment by their actions, their products, and by the attitudes of everyone at HSTpathways. Private Equity / Jun 05, 2026
See all 415 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Oil and Gas
Construction
Mobile
Payments
Retail
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Software
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Sudan
Norway
Malawi
Isle of Man
Haiti
Iran
Madagascar
Lesotho
Russian Federation
Nepal
Turkey
Liberia
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Armenia
Colombia
China
Côte d'Ivoire
Costa Rica
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Kazakhstan
Switzerland
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Novo Holdings invest in?

Novo Holdings invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Series B stage. Most of the 415 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Novo Holdings invest in?

Novo Holdings typically joins rounds of $9.5M–$133M at Series A, $15M–$135M at Series B and $35M–$118M at Series C. These are whole funding-round sizes, not Novo Holdings's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Novo Holdings took part in.

How do I contact Novo Holdings?

Public channels for Novo Holdings include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Novo Holdings?

The team at Novo Holdings includes Emmanuelle Coutanceau (Partner Novo Seeds), Steve Collins (National Account Executive) and Thomas Dyrberg (Partner), among 17 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Novo Holdings Novo Holdings Find emails